Prefilled Syringes Market to Hit 9.41 Billion, Globally, by 2030 at ... - InvestorsObserver
068760 Stock | KRW 59,800 1,300 2.13% |
About 62% of Celltrion Pharm's investor base is looking to short. The analysis of current outlook of investing in Celltrion Pharm suggests that many traders are alarmed regarding Celltrion Pharm's prospects. The current market sentiment, together with Celltrion Pharm's historical and current headlines, can help investors time the market. In addition, many technical investors use Celltrion Pharm stock news signals to limit their universe of possible portfolio assets.
Celltrion |
Prefilled Syringes Market to Hit 9.41 Billion, Globally, by 2030 at ... InvestorsObserver
Read at news.google.com
Celltrion Pharm Fundamental Analysis
We analyze Celltrion Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celltrion Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celltrion Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Celltrion Pharm is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Celltrion Pharm Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celltrion Pharm stock to make a market-neutral strategy. Peer analysis of Celltrion Pharm could also be used in its relative valuation, which is a method of valuing Celltrion Pharm by comparing valuation metrics with similar companies.
Peers
Celltrion Pharm Related Equities
039840 | DIO | 0.55 |
| ||
086900 | Medy Tox | 0.72 |
| ||
041830 | InBody CoLtd | 2.29 |
| ||
036830 | Soulbrain Holdings | 5.00 |
|
Complementary Tools for Celltrion Stock analysis
When running Celltrion Pharm's price analysis, check to measure Celltrion Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celltrion Pharm is operating at the current time. Most of Celltrion Pharm's value examination focuses on studying past and present price action to predict the probability of Celltrion Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celltrion Pharm's price. Additionally, you may evaluate how the addition of Celltrion Pharm to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |